Viyash Scientific Ltd

Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 5 May 2026. This shift reflects a complex interplay of deteriorating technical indicators, valuation pressures, and mixed financial trends despite recent strong quarterly results.

Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell. Despite a strong one-year return of 28.11%, recent technical signals suggest a sideways trend with bearish undertones, raising questions about the stock’s near-term trajectory.

Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 May 2026, providing investors with the latest insights into its performance and outlook.

Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Viyash Scientific Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, financial performance, valuation metrics, and overall quality. This shift comes amid a strong quarterly performance and evolving market dynamics, signalling cautious optimism for investors in the Pharmaceuticals & Biotechnology sector.

Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, signalling a potential turnaround after a period of sideways movement. The stock surged 7.50% on 9 Apr 2026, closing at ₹210.00, up from the previous close of ₹195.35, reflecting renewed investor interest amid mixed technical signals.

The Sensex climbed 3.95% on 8 Apr 2026, yet Viyash Scientific Ltd outpaced the broader market with a 7.5% gain, reaching an intraday high of Rs 210. This 6.68-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market lift.

Viyash Scientific Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 23 March 2026. This change reflects a complex interplay of deteriorating technical indicators, valuation pressures, and mixed financial trends despite recent strong quarterly results. The downgrade is underpinned by a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting growing investor caution amid recent price declines and sector headwinds.

Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 19 January 2026. While this rating change occurred in January, the analysis and financial metrics discussed here reflect the company’s current position as of 17 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 19 Jan 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Viyash Scientific Ltd experienced a significant intraday decline on 2 Mar 2026, touching a low of Rs 195.7, down 7.97% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and subdued market sentiment within the Pharmaceuticals & Biotechnology space.

Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 February 2026, providing investors with the latest insights into its performance and outlook.

Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 February 2026, providing investors with the most up-to-date insight into the stock’s performance and outlook.